Antiviral Type III CRISPR signalling via conjugation of ATP and AdoMet
H. Chi, V. Hoikkala, S. Gruschow, S. Graham, S. Shirran, M. F. White
This study identifies SAM-AMP as a novel second messenger in type III-B CRISPR systems, used for antiviral signaling by conjugating ATP to S-adenosyl methionine.
bioRxiv · Jun 26, 2023 · PreprintMicrobiology